Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System in Patients With Atrial Fibrillation

NCT07444320 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT07444320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07444320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System in Patients With Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
February 12, 2026
Completion date
February 29, 2028
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation, persistent atrial fibrillation